Emzor calls for API investment to tackle Nigeria’s malaria burden

Emzor is advocating for increased financial investment in active pharmaceutical ingredients to help alleviate the severe malaria burden affecting Nigeria. The pharmaceutical company suggests that directing resources toward these essential manufacturing components will significantly strengthen the national healthcare response and improve the management of the disease across the country.